Champignon Brands Files Required Disclosures With Exchange, Resumption Of Trading In Hands Of BCSC

Champignon Brands (CSE: SHRM) has completed the regulatory filings required as per the review previously initiated by the British Columbia Securities Commission (BCSC). With the documents filed late in the day on Tuesday, the company announced late this afternoon that it is now in compliance with the required filings.

The company was initially halted from trading in late June in connection with three business acquisition reports that were to be filed by the company. Business acquisition reports, or BAR for short, are required based on three tests: the asset test, where a target company’s assets amount to 20% or more of the acquiring firms assets, the investment test, which again is based around exceeding 20% of assets, or the profit and loss test, when the target firm’s profit or loss exceeds 20% of the acquiring firms profit or loss.

For Champignon, this meant that it was required to file reports on the acquisitions of Artisan Growers, Novo Formulations, and Tassili Life Sciences. With the company previously failing to complete these documents within the allotted time frame, it was halted for trading until such issues were rectified. The timing of the resumption of trading is now in the hands of the BCSC, whom is currently reviewing documentation filed by Champignon, as well as the disclosure obligations of the issuer.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Furthermore, the company announced this evening that Dr. Roger McIntyre, currently the CEO of Champignon, has replaced Pat McCutcheon on the firms Board of Directors. McCutcheon will remain as an advisor to the firm, which is said to “permit him increased mobility to assist the Company with ongoing and planned capital markets initiatives.”

Champignon Brands last traded at $0.89 on the CSE, and currently remains halted.


FULL DISCLOSURE: Champignon Brands is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Champignon Brands on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

One Response

  1. Why is Champignon Brands still halted? They haven’t said a word to shareholders, who have been stuck with no answers for months.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Champignon Brands Vs Mind Medicine: A Comparison

Champignon Brands (CSE: SHRM), prior to the public listing of the company, had a primary...

Monday, April 20, 2020, 09:01:13 AM

Champignon Brands Announces Name Change, Spin Out Of CPG Division

Champignon Brands (CSE: SHRM) announced after the bell last night that it intends to change...

Saturday, June 13, 2020, 11:39:46 AM

Champignon Brands Appoints Medipharm Labs CEO Pat McCutcheon to Board

This morning Champignon Brands Inc. (CSE: SHRM) announced the appointment of Pat McCutcheon to its...

Wednesday, May 6, 2020, 09:18:25 AM

Champignon Brands To Acquire Biotech Firm Novo Formulations

Champignon Brands (CSE: SHRM) announced today that they have signed a definitive agreement to acquire...

Thursday, March 19, 2020, 03:27:32 PM

Champignon Brands To Acquire Psilocybin Research Firm Tassili Life Sciences

Last night, Champignon Brands (CSE: SHRM) announced that they have signed a definitive agreement to...

Saturday, March 28, 2020, 01:12:34 PM